Global Amiodarone Hydrochloride Tablets Market Growth 2026-2032
The global Amiodarone Hydrochloride Tablets market size is predicted to grow from US$ 338 million in 2025 to US$ 467 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.
Amiodarone Hydrochloride Tablets are oral prescription medicines formulated to release alfuzosin gradually over an extended period. The product is primarily used to treat the signs and symptoms of benign prostatic hyperplasia in adult men by relaxing smooth muscle in the prostate and bladder neck and improving urinary flow.
Immediate-release tablets, alfuzosin active pharmaceutical ingredients, combination products, other alpha-blockers, medical examinations, surgical procedures and treatment services are excluded.
The average selling price in 2025 is approximately US$14.40 per unit, with global sales volume of approximately 24 million units and an estimated average gross margin of approximately 53%. Each unit is uniformly converted to a standard box of 30 tablets. In the actual market, there are packaging specifications of 10, 20, 30, 60 tablets, and other sizes; for the statistical purposes, all are converted to the standard 30-tablet packaging.
The upstream chain includes alfuzosin hydrochloride active pharmaceutical ingredients, controlled-release excipients, fillers, binders, lubricants, coating materials and pharmaceutical packaging. Midstream activities include formulation development, granulation, compression, controlled-release coating, quality testing, packaging, regulatory registration and batch release. Downstream participants include hospitals, clinics, retail pharmacies, online pharmacies, pharmaceutical distributors and patients receiving long-term treatment.
The market is primarily supported by the rising prevalence and diagnosis of benign prostatic hyperplasia among aging male populations. As life expectancy increases and more men undergo routine urological examinations, the number of patients receiving long-term treatment for lower urinary tract symptoms continues to grow.
Sustained-release formulations are preferred because they maintain drug exposure over a longer period and support once-daily dosing. The simpler dosing schedule can improve treatment adherence among elderly patients who may already be taking medicines for cardiovascular, metabolic and other chronic conditions.
Generic medicines account for a significant and increasing share of the market. Patent expiration and the entry of multiple generic suppliers have reduced treatment costs and improved product availability. However, generic competition also limits price growth, particularly in markets with centralized purchasing, reimbursement controls and strong pharmacy substitution.
Product quality remains important because sustained-release performance depends on formulation design, excipient selection and manufacturing consistency. Manufacturers must demonstrate appropriate dissolution profiles, bioequivalence, stability and batch consistency. Regulatory barriers are therefore higher than for conventional immediate-release tablets.
The market also faces competition from other medicines used for benign prostatic hyperplasia. Treatment selection is influenced by symptom severity, prostate size, cardiovascular condition, adverse-effect profile, physician preference and local clinical guidelines. Alfuzosin retains demand because of its established clinical use, but its growth is moderated by the availability of several alternative therapies.
North America and Europe represent mature markets with established diagnosis and prescription systems. Asia-Pacific is expected to provide stronger incremental growth due to population aging, improving access to urological care and increasing availability of lower-cost generic products. Supply opportunities are also expanding in Latin America, the Middle East and parts of Africa.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Amiodarone Hydrochloride Tablets Industry Forecast” looks at past sales and reviews total world Amiodarone Hydrochloride Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Amiodarone Hydrochloride Tablets sales for 2026 through 2032. With Amiodarone Hydrochloride Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amiodarone Hydrochloride Tablets industry.
This Insight Report provides a comprehensive analysis of the global Amiodarone Hydrochloride Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amiodarone Hydrochloride Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amiodarone Hydrochloride Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amiodarone Hydrochloride Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amiodarone Hydrochloride Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Amiodarone Hydrochloride Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Amiodarone Hydrochloride Tablets are oral prescription medicines formulated to release alfuzosin gradually over an extended period. The product is primarily used to treat the signs and symptoms of benign prostatic hyperplasia in adult men by relaxing smooth muscle in the prostate and bladder neck and improving urinary flow.
Immediate-release tablets, alfuzosin active pharmaceutical ingredients, combination products, other alpha-blockers, medical examinations, surgical procedures and treatment services are excluded.
The average selling price in 2025 is approximately US$14.40 per unit, with global sales volume of approximately 24 million units and an estimated average gross margin of approximately 53%. Each unit is uniformly converted to a standard box of 30 tablets. In the actual market, there are packaging specifications of 10, 20, 30, 60 tablets, and other sizes; for the statistical purposes, all are converted to the standard 30-tablet packaging.
The upstream chain includes alfuzosin hydrochloride active pharmaceutical ingredients, controlled-release excipients, fillers, binders, lubricants, coating materials and pharmaceutical packaging. Midstream activities include formulation development, granulation, compression, controlled-release coating, quality testing, packaging, regulatory registration and batch release. Downstream participants include hospitals, clinics, retail pharmacies, online pharmacies, pharmaceutical distributors and patients receiving long-term treatment.
The market is primarily supported by the rising prevalence and diagnosis of benign prostatic hyperplasia among aging male populations. As life expectancy increases and more men undergo routine urological examinations, the number of patients receiving long-term treatment for lower urinary tract symptoms continues to grow.
Sustained-release formulations are preferred because they maintain drug exposure over a longer period and support once-daily dosing. The simpler dosing schedule can improve treatment adherence among elderly patients who may already be taking medicines for cardiovascular, metabolic and other chronic conditions.
Generic medicines account for a significant and increasing share of the market. Patent expiration and the entry of multiple generic suppliers have reduced treatment costs and improved product availability. However, generic competition also limits price growth, particularly in markets with centralized purchasing, reimbursement controls and strong pharmacy substitution.
Product quality remains important because sustained-release performance depends on formulation design, excipient selection and manufacturing consistency. Manufacturers must demonstrate appropriate dissolution profiles, bioequivalence, stability and batch consistency. Regulatory barriers are therefore higher than for conventional immediate-release tablets.
The market also faces competition from other medicines used for benign prostatic hyperplasia. Treatment selection is influenced by symptom severity, prostate size, cardiovascular condition, adverse-effect profile, physician preference and local clinical guidelines. Alfuzosin retains demand because of its established clinical use, but its growth is moderated by the availability of several alternative therapies.
North America and Europe represent mature markets with established diagnosis and prescription systems. Asia-Pacific is expected to provide stronger incremental growth due to population aging, improving access to urological care and increasing availability of lower-cost generic products. Supply opportunities are also expanding in Latin America, the Middle East and parts of Africa.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Amiodarone Hydrochloride Tablets Industry Forecast” looks at past sales and reviews total world Amiodarone Hydrochloride Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Amiodarone Hydrochloride Tablets sales for 2026 through 2032. With Amiodarone Hydrochloride Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amiodarone Hydrochloride Tablets industry.
This Insight Report provides a comprehensive analysis of the global Amiodarone Hydrochloride Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amiodarone Hydrochloride Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amiodarone Hydrochloride Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amiodarone Hydrochloride Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amiodarone Hydrochloride Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Amiodarone Hydrochloride Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Below 30 Tablets
- 30–60 Tablets
- Above 60 Tablets
Segmentation by Prescription Duration:
- Below 30 Days
- 30–90 Days
- Above 90 Days
Segmentation by Release Technology:
- Matrix Sustained-Release Tablets
- Coated Sustained-Release Tablets
- Multilayer Controlled-Release Tablets
- Other Release Technologies
Segmentation by Application:
- Hospital
- Clinic
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi S.A.
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma Limited
- Apotex Inc.
- Wockhardt Limited
- Unichem Laboratories Limited
- Taj Pharmaceuticals Limited
- Trumac Healthcare
- Benta Pharma Industries
- Zentiva Group
- Sandoz Group AG
- Laboratorios Cinfa, S.A.
- Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
- Shandong Sine Pharmaceutical Co., Ltd.
- Ningbo Dahongying Pharmaceutical Co., Ltd.
- Sawai Pharmaceutical
- TOA EIYOTOA EIYO
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Amiodarone Hydrochloride Tablets market?
- What factors are driving Amiodarone Hydrochloride Tablets market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Amiodarone Hydrochloride Tablets market opportunities vary by end market size?
- How does Amiodarone Hydrochloride Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amiodarone Hydrochloride Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Amiodarone Hydrochloride Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Amiodarone Hydrochloride Tablets by Country/Region, 2021, 2025 & 2032
2.2 Amiodarone Hydrochloride Tablets Segment by Type
2.2.1 0.1g
2.2.2 0.2g
2.2.3 Amiodarone Hydrochloride Tablets Sales by Type
2.2.3.1 Global Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Amiodarone Hydrochloride Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Amiodarone Hydrochloride Tablets Sale Price by Type (2021-2026)
2.3 Amiodarone Hydrochloride Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Amiodarone Hydrochloride Tablets Sales by Application
2.3.4.1 Global Amiodarone Hydrochloride Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Amiodarone Hydrochloride Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Amiodarone Hydrochloride Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Amiodarone Hydrochloride Tablets Breakdown Data by Company
3.1.1 Global Amiodarone Hydrochloride Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Amiodarone Hydrochloride Tablets Sales Market Share by Company (2021-2026)
3.2 Global Amiodarone Hydrochloride Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Amiodarone Hydrochloride Tablets Revenue by Company (2021-2026)
3.2.2 Global Amiodarone Hydrochloride Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Amiodarone Hydrochloride Tablets Sale Price by Company
3.4 Key Manufacturers Amiodarone Hydrochloride Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amiodarone Hydrochloride Tablets Product Location Distribution
3.4.2 Players Amiodarone Hydrochloride Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AMIODARONE HYDROCHLORIDE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Amiodarone Hydrochloride Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Amiodarone Hydrochloride Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Amiodarone Hydrochloride Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Amiodarone Hydrochloride Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Amiodarone Hydrochloride Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Amiodarone Hydrochloride Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Amiodarone Hydrochloride Tablets Sales Growth
4.4 APAC Amiodarone Hydrochloride Tablets Sales Growth
4.5 Europe Amiodarone Hydrochloride Tablets Sales Growth
4.6 Middle East & Africa Amiodarone Hydrochloride Tablets Sales Growth
5 AMERICAS
5.1 Americas Amiodarone Hydrochloride Tablets Sales by Country
5.1.1 Americas Amiodarone Hydrochloride Tablets Sales by Country (2021-2026)
5.1.2 Americas Amiodarone Hydrochloride Tablets Revenue by Country (2021-2026)
5.2 Americas Amiodarone Hydrochloride Tablets Sales by Type (2021-2026)
5.3 Americas Amiodarone Hydrochloride Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amiodarone Hydrochloride Tablets Sales by Region
6.1.1 APAC Amiodarone Hydrochloride Tablets Sales by Region (2021-2026)
6.1.2 APAC Amiodarone Hydrochloride Tablets Revenue by Region (2021-2026)
6.2 APAC Amiodarone Hydrochloride Tablets Sales by Type (2021-2026)
6.3 APAC Amiodarone Hydrochloride Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amiodarone Hydrochloride Tablets by Country
7.1.1 Europe Amiodarone Hydrochloride Tablets Sales by Country (2021-2026)
7.1.2 Europe Amiodarone Hydrochloride Tablets Revenue by Country (2021-2026)
7.2 Europe Amiodarone Hydrochloride Tablets Sales by Type (2021-2026)
7.3 Europe Amiodarone Hydrochloride Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amiodarone Hydrochloride Tablets by Country
8.1.1 Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Amiodarone Hydrochloride Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amiodarone Hydrochloride Tablets
10.3 Manufacturing Process Analysis of Amiodarone Hydrochloride Tablets
10.4 Industry Chain Structure of Amiodarone Hydrochloride Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amiodarone Hydrochloride Tablets Distributors
11.3 Amiodarone Hydrochloride Tablets Customer
12 WORLD FORECAST REVIEW FOR AMIODARONE HYDROCHLORIDE TABLETS BY GEOGRAPHIC REGION
12.1 Global Amiodarone Hydrochloride Tablets Market Size Forecast by Region
12.1.1 Global Amiodarone Hydrochloride Tablets Forecast by Region (2027-2032)
12.1.2 Global Amiodarone Hydrochloride Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Amiodarone Hydrochloride Tablets Forecast by Type (2027-2032)
12.7 Global Amiodarone Hydrochloride Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Guilin Southern Medicine
13.1.1 Guilin Southern Medicine Company Information
13.1.2 Guilin Southern Medicine Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.1.3 Guilin Southern Medicine Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Guilin Southern Medicine Main Business Overview
13.1.5 Guilin Southern Medicine Latest Developments
13.2 Tianfang Pharmaceutical
13.2.1 Tianfang Pharmaceutical Company Information
13.2.2 Tianfang Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.2.3 Tianfang Pharmaceutical Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Tianfang Pharmaceutical Main Business Overview
13.2.5 Tianfang Pharmaceutical Latest Developments
13.3 Chongqing Kerui Pharmaceutical
13.3.1 Chongqing Kerui Pharmaceutical Company Information
13.3.2 Chongqing Kerui Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.3.3 Chongqing Kerui Pharmaceutical Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chongqing Kerui Pharmaceutical Main Business Overview
13.3.5 Chongqing Kerui Pharmaceutical Latest Developments
13.4 Guangzhou Baiyunshan Pharmaceutical Group
13.4.1 Guangzhou Baiyunshan Pharmaceutical Group Company Information
13.4.2 Guangzhou Baiyunshan Pharmaceutical Group Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.4.3 Guangzhou Baiyunshan Pharmaceutical Group Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Guangzhou Baiyunshan Pharmaceutical Group Main Business Overview
13.4.5 Guangzhou Baiyunshan Pharmaceutical Group Latest Developments
13.5 Hainan Pharmaceutical Factory
13.5.1 Hainan Pharmaceutical Factory Company Information
13.5.2 Hainan Pharmaceutical Factory Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.5.3 Hainan Pharmaceutical Factory Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hainan Pharmaceutical Factory Main Business Overview
13.5.5 Hainan Pharmaceutical Factory Latest Developments
13.6 Jiangxi Pharmaceutical
13.6.1 Jiangxi Pharmaceutical Company Information
13.6.2 Jiangxi Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.6.3 Jiangxi Pharmaceutical Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jiangxi Pharmaceutical Main Business Overview
13.6.5 Jiangxi Pharmaceutical Latest Developments
13.7 Jiangsu Enhuaside Pharmaceutical Co., Ltd.
13.7.1 Jiangsu Enhuaside Pharmaceutical Co., Ltd. Company Information
13.7.2 Jiangsu Enhuaside Pharmaceutical Co., Ltd. Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.7.3 Jiangsu Enhuaside Pharmaceutical Co., Ltd. Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangsu Enhuaside Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Jiangsu Enhuaside Pharmaceutical Co., Ltd. Latest Developments
13.8 Harbin Pharmaceutical Group
13.8.1 Harbin Pharmaceutical Group Company Information
13.8.2 Harbin Pharmaceutical Group Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.8.3 Harbin Pharmaceutical Group Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Harbin Pharmaceutical Group Main Business Overview
13.8.5 Harbin Pharmaceutical Group Latest Developments
13.9 Baxter
13.9.1 Baxter Company Information
13.9.2 Baxter Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.9.3 Baxter Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Baxter Main Business Overview
13.9.5 Baxter Latest Developments
13.10 AuroMedics
13.10.1 AuroMedics Company Information
13.10.2 AuroMedics Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.10.3 AuroMedics Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 AuroMedics Main Business Overview
13.10.5 AuroMedics Latest Developments
13.11 Fresenius Kabi
13.11.1 Fresenius Kabi Company Information
13.11.2 Fresenius Kabi Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.11.3 Fresenius Kabi Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Fresenius Kabi Main Business Overview
13.11.5 Fresenius Kabi Latest Developments
13.12 Hikma
13.12.1 Hikma Company Information
13.12.2 Hikma Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.12.3 Hikma Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Hikma Main Business Overview
13.12.5 Hikma Latest Developments
13.13 Mylan
13.13.1 Mylan Company Information
13.13.2 Mylan Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.13.3 Mylan Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Mylan Main Business Overview
13.13.5 Mylan Latest Developments
13.14 Sagent
13.14.1 Sagent Company Information
13.14.2 Sagent Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.14.3 Sagent Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sagent Main Business Overview
13.14.5 Sagent Latest Developments
13.15 Bioniche Pharma
13.15.1 Bioniche Pharma Company Information
13.15.2 Bioniche Pharma Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.15.3 Bioniche Pharma Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Bioniche Pharma Main Business Overview
13.15.5 Bioniche Pharma Latest Developments
13.16 Sanofi
13.16.1 Sanofi Company Information
13.16.2 Sanofi Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.16.3 Sanofi Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Sanofi Main Business Overview
13.16.5 Sanofi Latest Developments
13.17 Prism Pharmaceutical
13.17.1 Prism Pharmaceutical Company Information
13.17.2 Prism Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.17.3 Prism Pharmaceutical Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Prism Pharmaceutical Main Business Overview
13.17.5 Prism Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amiodarone Hydrochloride Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Amiodarone Hydrochloride Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Amiodarone Hydrochloride Tablets by Country/Region, 2021, 2025 & 2032
2.2 Amiodarone Hydrochloride Tablets Segment by Type
2.2.1 0.1g
2.2.2 0.2g
2.2.3 Amiodarone Hydrochloride Tablets Sales by Type
2.2.3.1 Global Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Amiodarone Hydrochloride Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Amiodarone Hydrochloride Tablets Sale Price by Type (2021-2026)
2.3 Amiodarone Hydrochloride Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Amiodarone Hydrochloride Tablets Sales by Application
2.3.4.1 Global Amiodarone Hydrochloride Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Amiodarone Hydrochloride Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Amiodarone Hydrochloride Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Amiodarone Hydrochloride Tablets Breakdown Data by Company
3.1.1 Global Amiodarone Hydrochloride Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Amiodarone Hydrochloride Tablets Sales Market Share by Company (2021-2026)
3.2 Global Amiodarone Hydrochloride Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Amiodarone Hydrochloride Tablets Revenue by Company (2021-2026)
3.2.2 Global Amiodarone Hydrochloride Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Amiodarone Hydrochloride Tablets Sale Price by Company
3.4 Key Manufacturers Amiodarone Hydrochloride Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amiodarone Hydrochloride Tablets Product Location Distribution
3.4.2 Players Amiodarone Hydrochloride Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AMIODARONE HYDROCHLORIDE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Amiodarone Hydrochloride Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Amiodarone Hydrochloride Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Amiodarone Hydrochloride Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Amiodarone Hydrochloride Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Amiodarone Hydrochloride Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Amiodarone Hydrochloride Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Amiodarone Hydrochloride Tablets Sales Growth
4.4 APAC Amiodarone Hydrochloride Tablets Sales Growth
4.5 Europe Amiodarone Hydrochloride Tablets Sales Growth
4.6 Middle East & Africa Amiodarone Hydrochloride Tablets Sales Growth
5 AMERICAS
5.1 Americas Amiodarone Hydrochloride Tablets Sales by Country
5.1.1 Americas Amiodarone Hydrochloride Tablets Sales by Country (2021-2026)
5.1.2 Americas Amiodarone Hydrochloride Tablets Revenue by Country (2021-2026)
5.2 Americas Amiodarone Hydrochloride Tablets Sales by Type (2021-2026)
5.3 Americas Amiodarone Hydrochloride Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amiodarone Hydrochloride Tablets Sales by Region
6.1.1 APAC Amiodarone Hydrochloride Tablets Sales by Region (2021-2026)
6.1.2 APAC Amiodarone Hydrochloride Tablets Revenue by Region (2021-2026)
6.2 APAC Amiodarone Hydrochloride Tablets Sales by Type (2021-2026)
6.3 APAC Amiodarone Hydrochloride Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amiodarone Hydrochloride Tablets by Country
7.1.1 Europe Amiodarone Hydrochloride Tablets Sales by Country (2021-2026)
7.1.2 Europe Amiodarone Hydrochloride Tablets Revenue by Country (2021-2026)
7.2 Europe Amiodarone Hydrochloride Tablets Sales by Type (2021-2026)
7.3 Europe Amiodarone Hydrochloride Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amiodarone Hydrochloride Tablets by Country
8.1.1 Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Amiodarone Hydrochloride Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amiodarone Hydrochloride Tablets
10.3 Manufacturing Process Analysis of Amiodarone Hydrochloride Tablets
10.4 Industry Chain Structure of Amiodarone Hydrochloride Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amiodarone Hydrochloride Tablets Distributors
11.3 Amiodarone Hydrochloride Tablets Customer
12 WORLD FORECAST REVIEW FOR AMIODARONE HYDROCHLORIDE TABLETS BY GEOGRAPHIC REGION
12.1 Global Amiodarone Hydrochloride Tablets Market Size Forecast by Region
12.1.1 Global Amiodarone Hydrochloride Tablets Forecast by Region (2027-2032)
12.1.2 Global Amiodarone Hydrochloride Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Amiodarone Hydrochloride Tablets Forecast by Type (2027-2032)
12.7 Global Amiodarone Hydrochloride Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Guilin Southern Medicine
13.1.1 Guilin Southern Medicine Company Information
13.1.2 Guilin Southern Medicine Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.1.3 Guilin Southern Medicine Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Guilin Southern Medicine Main Business Overview
13.1.5 Guilin Southern Medicine Latest Developments
13.2 Tianfang Pharmaceutical
13.2.1 Tianfang Pharmaceutical Company Information
13.2.2 Tianfang Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.2.3 Tianfang Pharmaceutical Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Tianfang Pharmaceutical Main Business Overview
13.2.5 Tianfang Pharmaceutical Latest Developments
13.3 Chongqing Kerui Pharmaceutical
13.3.1 Chongqing Kerui Pharmaceutical Company Information
13.3.2 Chongqing Kerui Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.3.3 Chongqing Kerui Pharmaceutical Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chongqing Kerui Pharmaceutical Main Business Overview
13.3.5 Chongqing Kerui Pharmaceutical Latest Developments
13.4 Guangzhou Baiyunshan Pharmaceutical Group
13.4.1 Guangzhou Baiyunshan Pharmaceutical Group Company Information
13.4.2 Guangzhou Baiyunshan Pharmaceutical Group Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.4.3 Guangzhou Baiyunshan Pharmaceutical Group Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Guangzhou Baiyunshan Pharmaceutical Group Main Business Overview
13.4.5 Guangzhou Baiyunshan Pharmaceutical Group Latest Developments
13.5 Hainan Pharmaceutical Factory
13.5.1 Hainan Pharmaceutical Factory Company Information
13.5.2 Hainan Pharmaceutical Factory Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.5.3 Hainan Pharmaceutical Factory Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hainan Pharmaceutical Factory Main Business Overview
13.5.5 Hainan Pharmaceutical Factory Latest Developments
13.6 Jiangxi Pharmaceutical
13.6.1 Jiangxi Pharmaceutical Company Information
13.6.2 Jiangxi Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.6.3 Jiangxi Pharmaceutical Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jiangxi Pharmaceutical Main Business Overview
13.6.5 Jiangxi Pharmaceutical Latest Developments
13.7 Jiangsu Enhuaside Pharmaceutical Co., Ltd.
13.7.1 Jiangsu Enhuaside Pharmaceutical Co., Ltd. Company Information
13.7.2 Jiangsu Enhuaside Pharmaceutical Co., Ltd. Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.7.3 Jiangsu Enhuaside Pharmaceutical Co., Ltd. Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangsu Enhuaside Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Jiangsu Enhuaside Pharmaceutical Co., Ltd. Latest Developments
13.8 Harbin Pharmaceutical Group
13.8.1 Harbin Pharmaceutical Group Company Information
13.8.2 Harbin Pharmaceutical Group Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.8.3 Harbin Pharmaceutical Group Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Harbin Pharmaceutical Group Main Business Overview
13.8.5 Harbin Pharmaceutical Group Latest Developments
13.9 Baxter
13.9.1 Baxter Company Information
13.9.2 Baxter Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.9.3 Baxter Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Baxter Main Business Overview
13.9.5 Baxter Latest Developments
13.10 AuroMedics
13.10.1 AuroMedics Company Information
13.10.2 AuroMedics Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.10.3 AuroMedics Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 AuroMedics Main Business Overview
13.10.5 AuroMedics Latest Developments
13.11 Fresenius Kabi
13.11.1 Fresenius Kabi Company Information
13.11.2 Fresenius Kabi Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.11.3 Fresenius Kabi Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Fresenius Kabi Main Business Overview
13.11.5 Fresenius Kabi Latest Developments
13.12 Hikma
13.12.1 Hikma Company Information
13.12.2 Hikma Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.12.3 Hikma Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Hikma Main Business Overview
13.12.5 Hikma Latest Developments
13.13 Mylan
13.13.1 Mylan Company Information
13.13.2 Mylan Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.13.3 Mylan Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Mylan Main Business Overview
13.13.5 Mylan Latest Developments
13.14 Sagent
13.14.1 Sagent Company Information
13.14.2 Sagent Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.14.3 Sagent Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sagent Main Business Overview
13.14.5 Sagent Latest Developments
13.15 Bioniche Pharma
13.15.1 Bioniche Pharma Company Information
13.15.2 Bioniche Pharma Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.15.3 Bioniche Pharma Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Bioniche Pharma Main Business Overview
13.15.5 Bioniche Pharma Latest Developments
13.16 Sanofi
13.16.1 Sanofi Company Information
13.16.2 Sanofi Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.16.3 Sanofi Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Sanofi Main Business Overview
13.16.5 Sanofi Latest Developments
13.17 Prism Pharmaceutical
13.17.1 Prism Pharmaceutical Company Information
13.17.2 Prism Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
13.17.3 Prism Pharmaceutical Amiodarone Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Prism Pharmaceutical Main Business Overview
13.17.5 Prism Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amiodarone Hydrochloride Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Amiodarone Hydrochloride Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.1g
Table 4. Major Players of 0.2g
Table 5. Global Amiodarone Hydrochloride Tablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
Table 7. Global Amiodarone Hydrochloride Tablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Type (2021-2026)
Table 9. Global Amiodarone Hydrochloride Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Amiodarone Hydrochloride Tablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Amiodarone Hydrochloride Tablets Sale Market Share by Application (2021-2026)
Table 12. Global Amiodarone Hydrochloride Tablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Application (2021-2026)
Table 14. Global Amiodarone Hydrochloride Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Amiodarone Hydrochloride Tablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Amiodarone Hydrochloride Tablets Sales Market Share by Company (2021-2026)
Table 17. Global Amiodarone Hydrochloride Tablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Company (2021-2026)
Table 19. Global Amiodarone Hydrochloride Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Amiodarone Hydrochloride Tablets Producing Area Distribution and Sales Area
Table 21. Players Amiodarone Hydrochloride Tablets Products Offered
Table 22. Amiodarone Hydrochloride Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Amiodarone Hydrochloride Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Amiodarone Hydrochloride Tablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Amiodarone Hydrochloride Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Amiodarone Hydrochloride Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Amiodarone Hydrochloride Tablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Amiodarone Hydrochloride Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Amiodarone Hydrochloride Tablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Amiodarone Hydrochloride Tablets Sales Market Share by Country (2021-2026)
Table 35. Americas Amiodarone Hydrochloride Tablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Amiodarone Hydrochloride Tablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Amiodarone Hydrochloride Tablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Amiodarone Hydrochloride Tablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Amiodarone Hydrochloride Tablets Sales Market Share by Region (2021-2026)
Table 40. APAC Amiodarone Hydrochloride Tablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Amiodarone Hydrochloride Tablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Amiodarone Hydrochloride Tablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Amiodarone Hydrochloride Tablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Amiodarone Hydrochloride Tablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Amiodarone Hydrochloride Tablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Amiodarone Hydrochloride Tablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Amiodarone Hydrochloride Tablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Amiodarone Hydrochloride Tablets
Table 52. Key Market Challenges & Risks of Amiodarone Hydrochloride Tablets
Table 53. Key Industry Trends of Amiodarone Hydrochloride Tablets
Table 54. Amiodarone Hydrochloride Tablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Amiodarone Hydrochloride Tablets Distributors List
Table 57. Amiodarone Hydrochloride Tablets Customer List
Table 58. Global Amiodarone Hydrochloride Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Amiodarone Hydrochloride Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Amiodarone Hydrochloride Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Amiodarone Hydrochloride Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Amiodarone Hydrochloride Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Amiodarone Hydrochloride Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Amiodarone Hydrochloride Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Amiodarone Hydrochloride Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Amiodarone Hydrochloride Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Amiodarone Hydrochloride Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Amiodarone Hydrochloride Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Amiodarone Hydrochloride Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Amiodarone Hydrochloride Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Amiodarone Hydrochloride Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Guilin Southern Medicine Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Guilin Southern Medicine Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 74. Guilin Southern Medicine Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Guilin Southern Medicine Main Business
Table 76. Guilin Southern Medicine Latest Developments
Table 77. Tianfang Pharmaceutical Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Tianfang Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 79. Tianfang Pharmaceutical Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Tianfang Pharmaceutical Main Business
Table 81. Tianfang Pharmaceutical Latest Developments
Table 82. Chongqing Kerui Pharmaceutical Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Chongqing Kerui Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 84. Chongqing Kerui Pharmaceutical Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Chongqing Kerui Pharmaceutical Main Business
Table 86. Chongqing Kerui Pharmaceutical Latest Developments
Table 87. Guangzhou Baiyunshan Pharmaceutical Group Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Guangzhou Baiyunshan Pharmaceutical Group Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 89. Guangzhou Baiyunshan Pharmaceutical Group Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Guangzhou Baiyunshan Pharmaceutical Group Main Business
Table 91. Guangzhou Baiyunshan Pharmaceutical Group Latest Developments
Table 92. Hainan Pharmaceutical Factory Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Hainan Pharmaceutical Factory Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 94. Hainan Pharmaceutical Factory Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hainan Pharmaceutical Factory Main Business
Table 96. Hainan Pharmaceutical Factory Latest Developments
Table 97. Jiangxi Pharmaceutical Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangxi Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 99. Jiangxi Pharmaceutical Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Jiangxi Pharmaceutical Main Business
Table 101. Jiangxi Pharmaceutical Latest Developments
Table 102. Jiangsu Enhuaside Pharmaceutical Co., Ltd. Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Jiangsu Enhuaside Pharmaceutical Co., Ltd. Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 104. Jiangsu Enhuaside Pharmaceutical Co., Ltd. Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Jiangsu Enhuaside Pharmaceutical Co., Ltd. Main Business
Table 106. Jiangsu Enhuaside Pharmaceutical Co., Ltd. Latest Developments
Table 107. Harbin Pharmaceutical Group Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Harbin Pharmaceutical Group Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 109. Harbin Pharmaceutical Group Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Harbin Pharmaceutical Group Main Business
Table 111. Harbin Pharmaceutical Group Latest Developments
Table 112. Baxter Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Baxter Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 114. Baxter Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Baxter Main Business
Table 116. Baxter Latest Developments
Table 117. AuroMedics Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 118. AuroMedics Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 119. AuroMedics Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. AuroMedics Main Business
Table 121. AuroMedics Latest Developments
Table 122. Fresenius Kabi Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 123. Fresenius Kabi Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 124. Fresenius Kabi Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Fresenius Kabi Main Business
Table 126. Fresenius Kabi Latest Developments
Table 127. Hikma Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 128. Hikma Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 129. Hikma Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Hikma Main Business
Table 131. Hikma Latest Developments
Table 132. Mylan Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 133. Mylan Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 134. Mylan Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Mylan Main Business
Table 136. Mylan Latest Developments
Table 137. Sagent Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 138. Sagent Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 139. Sagent Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Sagent Main Business
Table 141. Sagent Latest Developments
Table 142. Bioniche Pharma Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 143. Bioniche Pharma Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 144. Bioniche Pharma Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Bioniche Pharma Main Business
Table 146. Bioniche Pharma Latest Developments
Table 147. Sanofi Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 148. Sanofi Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 149. Sanofi Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Sanofi Main Business
Table 151. Sanofi Latest Developments
Table 152. Prism Pharmaceutical Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 153. Prism Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 154. Prism Pharmaceutical Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Prism Pharmaceutical Main Business
Table 156. Prism Pharmaceutical Latest Developments
Table 1. Amiodarone Hydrochloride Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Amiodarone Hydrochloride Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.1g
Table 4. Major Players of 0.2g
Table 5. Global Amiodarone Hydrochloride Tablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
Table 7. Global Amiodarone Hydrochloride Tablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Type (2021-2026)
Table 9. Global Amiodarone Hydrochloride Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Amiodarone Hydrochloride Tablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Amiodarone Hydrochloride Tablets Sale Market Share by Application (2021-2026)
Table 12. Global Amiodarone Hydrochloride Tablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Application (2021-2026)
Table 14. Global Amiodarone Hydrochloride Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Amiodarone Hydrochloride Tablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Amiodarone Hydrochloride Tablets Sales Market Share by Company (2021-2026)
Table 17. Global Amiodarone Hydrochloride Tablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Company (2021-2026)
Table 19. Global Amiodarone Hydrochloride Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Amiodarone Hydrochloride Tablets Producing Area Distribution and Sales Area
Table 21. Players Amiodarone Hydrochloride Tablets Products Offered
Table 22. Amiodarone Hydrochloride Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Amiodarone Hydrochloride Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Amiodarone Hydrochloride Tablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Amiodarone Hydrochloride Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Amiodarone Hydrochloride Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Amiodarone Hydrochloride Tablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Amiodarone Hydrochloride Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Amiodarone Hydrochloride Tablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Amiodarone Hydrochloride Tablets Sales Market Share by Country (2021-2026)
Table 35. Americas Amiodarone Hydrochloride Tablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Amiodarone Hydrochloride Tablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Amiodarone Hydrochloride Tablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Amiodarone Hydrochloride Tablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Amiodarone Hydrochloride Tablets Sales Market Share by Region (2021-2026)
Table 40. APAC Amiodarone Hydrochloride Tablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Amiodarone Hydrochloride Tablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Amiodarone Hydrochloride Tablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Amiodarone Hydrochloride Tablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Amiodarone Hydrochloride Tablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Amiodarone Hydrochloride Tablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Amiodarone Hydrochloride Tablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Amiodarone Hydrochloride Tablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Amiodarone Hydrochloride Tablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Amiodarone Hydrochloride Tablets
Table 52. Key Market Challenges & Risks of Amiodarone Hydrochloride Tablets
Table 53. Key Industry Trends of Amiodarone Hydrochloride Tablets
Table 54. Amiodarone Hydrochloride Tablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Amiodarone Hydrochloride Tablets Distributors List
Table 57. Amiodarone Hydrochloride Tablets Customer List
Table 58. Global Amiodarone Hydrochloride Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Amiodarone Hydrochloride Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Amiodarone Hydrochloride Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Amiodarone Hydrochloride Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Amiodarone Hydrochloride Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Amiodarone Hydrochloride Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Amiodarone Hydrochloride Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Amiodarone Hydrochloride Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Amiodarone Hydrochloride Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Amiodarone Hydrochloride Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Amiodarone Hydrochloride Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Amiodarone Hydrochloride Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Amiodarone Hydrochloride Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Amiodarone Hydrochloride Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Guilin Southern Medicine Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Guilin Southern Medicine Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 74. Guilin Southern Medicine Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Guilin Southern Medicine Main Business
Table 76. Guilin Southern Medicine Latest Developments
Table 77. Tianfang Pharmaceutical Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Tianfang Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 79. Tianfang Pharmaceutical Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Tianfang Pharmaceutical Main Business
Table 81. Tianfang Pharmaceutical Latest Developments
Table 82. Chongqing Kerui Pharmaceutical Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Chongqing Kerui Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 84. Chongqing Kerui Pharmaceutical Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Chongqing Kerui Pharmaceutical Main Business
Table 86. Chongqing Kerui Pharmaceutical Latest Developments
Table 87. Guangzhou Baiyunshan Pharmaceutical Group Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Guangzhou Baiyunshan Pharmaceutical Group Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 89. Guangzhou Baiyunshan Pharmaceutical Group Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Guangzhou Baiyunshan Pharmaceutical Group Main Business
Table 91. Guangzhou Baiyunshan Pharmaceutical Group Latest Developments
Table 92. Hainan Pharmaceutical Factory Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Hainan Pharmaceutical Factory Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 94. Hainan Pharmaceutical Factory Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hainan Pharmaceutical Factory Main Business
Table 96. Hainan Pharmaceutical Factory Latest Developments
Table 97. Jiangxi Pharmaceutical Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangxi Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 99. Jiangxi Pharmaceutical Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Jiangxi Pharmaceutical Main Business
Table 101. Jiangxi Pharmaceutical Latest Developments
Table 102. Jiangsu Enhuaside Pharmaceutical Co., Ltd. Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Jiangsu Enhuaside Pharmaceutical Co., Ltd. Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 104. Jiangsu Enhuaside Pharmaceutical Co., Ltd. Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Jiangsu Enhuaside Pharmaceutical Co., Ltd. Main Business
Table 106. Jiangsu Enhuaside Pharmaceutical Co., Ltd. Latest Developments
Table 107. Harbin Pharmaceutical Group Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Harbin Pharmaceutical Group Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 109. Harbin Pharmaceutical Group Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Harbin Pharmaceutical Group Main Business
Table 111. Harbin Pharmaceutical Group Latest Developments
Table 112. Baxter Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Baxter Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 114. Baxter Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Baxter Main Business
Table 116. Baxter Latest Developments
Table 117. AuroMedics Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 118. AuroMedics Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 119. AuroMedics Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. AuroMedics Main Business
Table 121. AuroMedics Latest Developments
Table 122. Fresenius Kabi Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 123. Fresenius Kabi Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 124. Fresenius Kabi Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Fresenius Kabi Main Business
Table 126. Fresenius Kabi Latest Developments
Table 127. Hikma Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 128. Hikma Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 129. Hikma Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Hikma Main Business
Table 131. Hikma Latest Developments
Table 132. Mylan Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 133. Mylan Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 134. Mylan Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Mylan Main Business
Table 136. Mylan Latest Developments
Table 137. Sagent Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 138. Sagent Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 139. Sagent Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Sagent Main Business
Table 141. Sagent Latest Developments
Table 142. Bioniche Pharma Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 143. Bioniche Pharma Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 144. Bioniche Pharma Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Bioniche Pharma Main Business
Table 146. Bioniche Pharma Latest Developments
Table 147. Sanofi Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 148. Sanofi Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 149. Sanofi Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Sanofi Main Business
Table 151. Sanofi Latest Developments
Table 152. Prism Pharmaceutical Basic Information, Amiodarone Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 153. Prism Pharmaceutical Amiodarone Hydrochloride Tablets Product Portfolios and Specifications
Table 154. Prism Pharmaceutical Amiodarone Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Prism Pharmaceutical Main Business
Table 156. Prism Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Amiodarone Hydrochloride Tablets
Figure 2. Amiodarone Hydrochloride Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amiodarone Hydrochloride Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Amiodarone Hydrochloride Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Amiodarone Hydrochloride Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Amiodarone Hydrochloride Tablets Sales Market Share by Country/Region (2025)
Figure 10. Amiodarone Hydrochloride Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.1g
Figure 12. Product Picture of 0.2g
Figure 13. Global Amiodarone Hydrochloride Tablets Sales Market Share by Type in 2026
Figure 14. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Type (2021-2026)
Figure 15. Amiodarone Hydrochloride Tablets Consumed in Hospital
Figure 16. Global Amiodarone Hydrochloride Tablets Market: Hospital (2021-2026) & (K Units)
Figure 17. Amiodarone Hydrochloride Tablets Consumed in Clinic
Figure 18. Global Amiodarone Hydrochloride Tablets Market: Clinic (2021-2026) & (K Units)
Figure 19. Amiodarone Hydrochloride Tablets Consumed in Other
Figure 20. Global Amiodarone Hydrochloride Tablets Market: Other (2021-2026) & (K Units)
Figure 21. Global Amiodarone Hydrochloride Tablets Sale Market Share by Application (2025)
Figure 22. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Application in 2026
Figure 23. Amiodarone Hydrochloride Tablets Sales by Company in 2026 (K Units)
Figure 24. Global Amiodarone Hydrochloride Tablets Sales Market Share by Company in 2026
Figure 25. Amiodarone Hydrochloride Tablets Revenue by Company in 2026 ($ millions)
Figure 26. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Company in 2026
Figure 27. Global Amiodarone Hydrochloride Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Amiodarone Hydrochloride Tablets Sales 2021-2026 (K Units)
Figure 30. Americas Amiodarone Hydrochloride Tablets Revenue 2021-2026 ($ millions)
Figure 31. APAC Amiodarone Hydrochloride Tablets Sales 2021-2026 (K Units)
Figure 32. APAC Amiodarone Hydrochloride Tablets Revenue 2021-2026 ($ millions)
Figure 33. Europe Amiodarone Hydrochloride Tablets Sales 2021-2026 (K Units)
Figure 34. Europe Amiodarone Hydrochloride Tablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Amiodarone Hydrochloride Tablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Amiodarone Hydrochloride Tablets Revenue 2021-2026 ($ millions)
Figure 37. Americas Amiodarone Hydrochloride Tablets Sales Market Share by Country in 2026
Figure 38. Americas Amiodarone Hydrochloride Tablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
Figure 40. Americas Amiodarone Hydrochloride Tablets Sales Market Share by Application (2021-2026)
Figure 41. United States Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Amiodarone Hydrochloride Tablets Sales Market Share by Region in 2026
Figure 46. APAC Amiodarone Hydrochloride Tablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
Figure 48. APAC Amiodarone Hydrochloride Tablets Sales Market Share by Application (2021-2026)
Figure 49. China Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Amiodarone Hydrochloride Tablets Sales Market Share by Country in 2026
Figure 57. Europe Amiodarone Hydrochloride Tablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
Figure 59. Europe Amiodarone Hydrochloride Tablets Sales Market Share by Application (2021-2026)
Figure 60. Germany Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Amiodarone Hydrochloride Tablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Amiodarone Hydrochloride Tablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Amiodarone Hydrochloride Tablets in 2026
Figure 74. Manufacturing Process Analysis of Amiodarone Hydrochloride Tablets
Figure 75. Industry Chain Structure of Amiodarone Hydrochloride Tablets
Figure 76. Channels of Distribution
Figure 77. Global Amiodarone Hydrochloride Tablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global Amiodarone Hydrochloride Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Amiodarone Hydrochloride Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Amiodarone Hydrochloride Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Amiodarone Hydrochloride Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Amiodarone Hydrochloride Tablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Amiodarone Hydrochloride Tablets
Figure 2. Amiodarone Hydrochloride Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amiodarone Hydrochloride Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Amiodarone Hydrochloride Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Amiodarone Hydrochloride Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Amiodarone Hydrochloride Tablets Sales Market Share by Country/Region (2025)
Figure 10. Amiodarone Hydrochloride Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.1g
Figure 12. Product Picture of 0.2g
Figure 13. Global Amiodarone Hydrochloride Tablets Sales Market Share by Type in 2026
Figure 14. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Type (2021-2026)
Figure 15. Amiodarone Hydrochloride Tablets Consumed in Hospital
Figure 16. Global Amiodarone Hydrochloride Tablets Market: Hospital (2021-2026) & (K Units)
Figure 17. Amiodarone Hydrochloride Tablets Consumed in Clinic
Figure 18. Global Amiodarone Hydrochloride Tablets Market: Clinic (2021-2026) & (K Units)
Figure 19. Amiodarone Hydrochloride Tablets Consumed in Other
Figure 20. Global Amiodarone Hydrochloride Tablets Market: Other (2021-2026) & (K Units)
Figure 21. Global Amiodarone Hydrochloride Tablets Sale Market Share by Application (2025)
Figure 22. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Application in 2026
Figure 23. Amiodarone Hydrochloride Tablets Sales by Company in 2026 (K Units)
Figure 24. Global Amiodarone Hydrochloride Tablets Sales Market Share by Company in 2026
Figure 25. Amiodarone Hydrochloride Tablets Revenue by Company in 2026 ($ millions)
Figure 26. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Company in 2026
Figure 27. Global Amiodarone Hydrochloride Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Amiodarone Hydrochloride Tablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Amiodarone Hydrochloride Tablets Sales 2021-2026 (K Units)
Figure 30. Americas Amiodarone Hydrochloride Tablets Revenue 2021-2026 ($ millions)
Figure 31. APAC Amiodarone Hydrochloride Tablets Sales 2021-2026 (K Units)
Figure 32. APAC Amiodarone Hydrochloride Tablets Revenue 2021-2026 ($ millions)
Figure 33. Europe Amiodarone Hydrochloride Tablets Sales 2021-2026 (K Units)
Figure 34. Europe Amiodarone Hydrochloride Tablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Amiodarone Hydrochloride Tablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Amiodarone Hydrochloride Tablets Revenue 2021-2026 ($ millions)
Figure 37. Americas Amiodarone Hydrochloride Tablets Sales Market Share by Country in 2026
Figure 38. Americas Amiodarone Hydrochloride Tablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
Figure 40. Americas Amiodarone Hydrochloride Tablets Sales Market Share by Application (2021-2026)
Figure 41. United States Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Amiodarone Hydrochloride Tablets Sales Market Share by Region in 2026
Figure 46. APAC Amiodarone Hydrochloride Tablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
Figure 48. APAC Amiodarone Hydrochloride Tablets Sales Market Share by Application (2021-2026)
Figure 49. China Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Amiodarone Hydrochloride Tablets Sales Market Share by Country in 2026
Figure 57. Europe Amiodarone Hydrochloride Tablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
Figure 59. Europe Amiodarone Hydrochloride Tablets Sales Market Share by Application (2021-2026)
Figure 60. Germany Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Amiodarone Hydrochloride Tablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Amiodarone Hydrochloride Tablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Amiodarone Hydrochloride Tablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Amiodarone Hydrochloride Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Amiodarone Hydrochloride Tablets in 2026
Figure 74. Manufacturing Process Analysis of Amiodarone Hydrochloride Tablets
Figure 75. Industry Chain Structure of Amiodarone Hydrochloride Tablets
Figure 76. Channels of Distribution
Figure 77. Global Amiodarone Hydrochloride Tablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global Amiodarone Hydrochloride Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Amiodarone Hydrochloride Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Amiodarone Hydrochloride Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Amiodarone Hydrochloride Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Amiodarone Hydrochloride Tablets Revenue Market Share Forecast by Application (2027-2032)
